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Abstract 
Whilst the role of the Disrupted-in-Schizophrenia 1 (DISC1) gene in the aetiology of major mental illnesses is 
debated, the characterisation of its function lends it credibility as a candidate. A key aspect of this functional 
characterisation is the determination of the role of common non-synonymous polymorphisms on normal 
variation within these functions. The common allele (A) of the DISC1 SNP rs821616 encodes a serine at the 
Ser704Cys polymorphism, and has been shown to increase the phosphorylation of extracellular signal-
regulated protein Kinases 1 and 2 (ERK1/2) which stimulate the phosphorylation of tyrosine hydroxylase, the 
rate-limiting enzyme for dopamine biosynthesis. We therefore set out to test the hypothesis that human serine 
(A) homozygotes would show elevated dopamine synthesis capacity compared to cysteine homozygotes and 
heterozygotes (TT and AT) for rs821616. [18F]-DOPA PET was used to index striatal dopamine synthesis 
capacity as the influx rate constant Ki
cer
 in healthy volunteers DISC1 rs821616 serine homozygotes (N=46) 
and healthy volunteers DISC1 rs821616 cysteine homozygotes and heterozygotes (N=56), matched for age, 
gender, ethnicity and using three scanners. We found DISC1 rs821616 serine homozygotes exhibited a 
significantly higher striatal Ki
cer compared to cysteine homozygotes and heterozygotes (p=0.012) explaining 
6.4% of the variance (partial eta squared=0.064). Our finding is consistent with its previous association with 
heightened activation of ERK1/2, which stimulates tyrosine hydroxylase activity for dopamine synthesis. This 
could be a potential mechanism mediating risk for psychosis, lending further credibility to the fact that DISC1 
is of functional interest in the aetiology of major mental illness. 
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Introduction 
The dopamine hypothesis has been a leading theory underlying the neurobiology of schizophrenia for 
the last four decades (1, 2). The hypothesis was initially based on evidence showing that antipsychotic 
medications block dopamine receptors (3-5) and that drugs increasing dopamine levels elicit psychotic 
symptoms in healthy people (6-8) and people with schizophrenia (9, 10). Using [
18
F] fluoro-3,4-
dihydroxyphenyl-L-alanine (F-DOPA) Positron Emission Tomography (PET), increased presynaptic 
dopamine synthesis capacity has been found in schizophrenia (11), people with prodromal psychotic 
symptoms (12, 13) and those with clinical progression to psychosis (14). Whilst a substantial body of 
evidence supports the role of increased presynaptic dopamine synthesis capacity in the pathoaetiology 
of psychosis, little is known about how genetic factors affect the implicated dopamine system(s) (15). 
 
The Disrupted-in-Schizophrenia 1 (DISC1) gene was originally discovered at the breakpoint of a 
balanced t(1;11) (q42;q14.3) translocation in a Scottish family with a high-prevalence of psychiatric 
disorders including schizophrenia (16-18). Further evidence for a link between DISC1 and psychotic 
and affective disorders emerged from the follow-up of families displaying rare DISC1 mutations (19, 
20) and large family-based studies in the population isolate of Finland (21-23) although a large meta-
analysis of families did not observe linkage at this region (24). Furthermore, evidence from individual 
population-based cohorts has been inconsistent (25, 26) leading to ongoing debate on its involvement 
in schizophrenia (27, 28). Whilst this controversy remains unresolved, there is value in seeking 
convergent evidence via studies elucidating the functional impact of the gene and its variations (29-
32). DISC1 is a scaffold protein involved in a wide range of neuronal functions including neuro-
signalling (30, 33). Preclinical studies show that DISC1 variant models exhibit increased 
amphetamine-induced dopamine release in the ventral striatum (see (34-37) reviewed in (38), 
indicating that DISC1 variations might affect presynaptic dopamine synthesis capacity. 
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One of the most studied DISC1 single nucleotide polymorphisms (SNPs) is rs821616 which is a non-
synonymous mutation leading to the translation of a serine (A allele) or a cysteine (T allele) at codon 
704 in exon 11 (39). Importantly, this polymorphism represents therefore not only a variation at the 
genetic sequence level but also at the protein sequence level of DISC1. At a molecular level, 
Hashimoto et al. (2006) found that overexpression of the serine variant of codon 704 by viral 
transduction resulted in a significant increase in phosphorylated ERK1/2, the more biologically active 
form (40). ERK1/2 in turn regulates the state of phosphorylation of tyrosine hydroxylase, the rate-
limiting enzyme for dopamine biosynthesis, to increase its activity and subsequent dopamine synthesis 
by up to two-fold (41-44). Dopamine is synthesized by converting first tyrosine into dihydroxyphenyl-
L-alanine (L-DOPA) by tyrosine hydroxylase, and second dihydroxyphenyl-L-alanine (L-DOPA) into 
dopamine by aromatic acid decarboxylase (45). [
18
F]-DOPA PET signal reflects aromatic acid 
decarboxylase function and dopamine storage capacity (45), but not directly tyrosine hydroxylase 
function. However, it should be noted that 1) tyrosine hydroxylase is the rate limiting step for 
dopamine synthesis capacity (43) and 2) the topological distribution of the [18F]-DOPA signal 
correlates highly with tyrosine hydroxylase immunostaining in unilaterally 6-hydroxydopamine (6-
OHDA)-lesioned rats, thus indicating that the [
18
F]-DOPA signal is strongly influenced by 
endogenous dopamine formed by tyrosine hydroxylase (46). 
 
In summary, preclinical findings suggest that the Ser704Cys variation affects dopamine synthesis by 
regulating ERK1/2 and its control over tyrosine hydroxylase activity. However, it remains unknown 
whether the Ser704Cys variation is associated with altered dopamine synthesis in humans. The aim of 
this study was therefore to test the hypothesis that serine homozygotes would exhibit increased striatal 
dopamine synthesis capacity relative to cysteine homozygotes and heterozygotes. 
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Results 
Demographics, scan parameters including the injected dose and substance use characteristics are 
shown in table 1. A total of 46 serine homozygotes and 56 cysteine homozygotes and heterozygotes 
(which encompass 45 heterozygotes and 11 cysteine homozygotes) were included in the study. The 
genotype frequencies (shown in table 1) did not significantly deviate from Hardy–Weinberg 
equilibrium (χ2 =1.422 with p=0.233), with a Minor Allele Frequency (T allele) of 0.335. Age (year) 
and Ki
cer
 (1/min) in the striatum were normally distributed across the two groups whereas injected dose 
(MBq) was not. There was no significant difference in age between groups t(100)=1.588, p=0.115 
(independent t test) and no significant difference in injected dose p=0.408 (Mann Whitney test). 
Levene’s test indicated no difference between the variances in the two groups, F=0.398, p=0.529. The 
univariate ANCOVA showed that the main effect of the DISC1 SNP rs821616 on the dopamine 
synthesis capacity in the striatum was significant, F (1,96) = 6.555, p=0.012, partial eta squared 
=0.064. The effects of the covariates were: for scanner, F(1,96)=16.573, p<0.01, age, F(1,96)=1.056, 
p=0.307, gender, F(1,96)=0.114, p=0.736 and ethnicity, F(1,96)=0.061, p=0.805. 
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Discussion 
In line with our hypothesis, we found that participants serine homozygotes (AA genotype) for the 
Ser704Cys functional DISC1 polymorphism exhibited a significantly greater Ki
cer value in the 
striatum, indicating greater dopamine synthesis capacity compared to cysteine homozygotes and 
heterozygotes (AT or TT genotype). This result is in accordance with preclinical evidence showing 
that the serine 704 DISC1 variant increases the activity of ERK1/2, which in turn enhances the 
phosphorylation of tyrosine hydroxylase, the rate limiting step in dopamine synthesis (41, 47). 
Limitations 
The main limitation of this study was that we used data from three different PET scanners, which 
could add error variance. However, scanner was included as a covariate to adjust for this. Furthermore, 
the effect of the Ser704Cys polymorphism remained significant when we only included subjects from 
PET scanner 2 (F(1,28) = 5.273, p=0.029 (N=16 cysteine homozygotes and heterozygotes, N=17 
serine homozygotes)), but not PET scanner 1 only (F(1,30) = 0.766, p=0.388, (N=19 cysteine 
homozygotes and heterozygotes, N=16 serine homozygotes)) and PET scanner 3 only (F(1,29) = 
0.426, p=0.519, (N=21 cysteine homozygotes and heterozygotes, N=13 serine homozygotes)). It is 
important to recognise that we measured the final step in the synthesis of dopamine, the conversion of 
L-DOPA into dopamine via aromatic acid decarboxylase (AADC). However, the parameter measured 
could be affected by other variables including the uptake of L-DOPA into the brain, although this 
should be controlled for by the reference region and there is no a priori reason to consider that this 
should be affected by the DISC1 protein. Importantly, this polymorphism was chosen based on a 
specific prior hypothesis. Although there was evidence to reject the null hypothesis, the p-value would 
not survive genome-wide correction and therefore the result requires replication. 
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Implications for mental disorders 
The Ser704Cys polymorphism has been associated with schizophrenia with an odds ratio in the range 
of 1.3 – 4.18 in various populations including European (48), mixed European/African-American (49), 
and Chinese Han (50-52). Inconsistencies have been found, with some studies indicating increased 
risk associated with the serine (A) allele (48, 51), whilst others the cysteine (T) (allele) (50, 52) and no 
association found (25) mainly in the Japanese population (53-55). A recent meta-analysis has also 
reported association of the serine allele with schizophrenia in Chinese (OR=1.338) and Japanese 
populations (OR=1.524), as well as in the overall mixed race sample (56). The inconsistencies in these 
results might be due to different ethnic populations. It should be noted that ever expanding studies of 
European ancestry population level genetic variants in schizophrenia continually demonstrate no 
significant associations at the entire DISC1 locus (57, 58), although there is evidence implicating the 
DISC1 interactor phosphodiesterase 4B (PDE4B) as a genome-wide significant single gene locus in a 
recent large schizophrenia genome-wide association study (GWAS) (58). Whilst GWAS have made 
crucial advances in the understanding of the genetic of schizophrenia, the biological mechanisms 
directly underlying the disorder remain yet poorly elucidated (59-61). In this context, the DISC1 
protein has been suggested as a biological candidate of interest for investigating molecular 
mechanisms of mental illnesses at the protein levels (33, 62). Beyond studies of dichotomous 
diagnoses, the serine allele has also been associated with increased risk for poor concentration among 
Korean patients with schizophrenia (63), increased severity of positive symptoms and hallucinations in 
European patients with First-Episode Psychosis (64) and increased lifetime severity of delusions in 
European patients with schizophrenia (65). A potential mechanism for the increased risk could be by 
dysregulating the control of dopamine to lead to increased dopamine synthesis. Findings in prodromal 
populations show that increased dopamine synthesis is associated with increased risk for psychosis 
(12, 13). The difference in dopamine synthesis capacity we observe here between serine homozygotes 
and carriers of the alternative allele is much smaller than the differences seen in at risk subjects (14, 
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66). It is therefore likely that the Ser704Cys variant interacts with other genetic changes to mediate 
risk, potentially by affecting dopamine synthesis.  
 
The fact that the common serine allele has been described as the risk allele is compatible with 
schizophrenia GWAS, in which approximately 50% of the implicated index SNPs are the more 
common alleles (67). At the population level, the genetic susceptibility to schizophrenia is caused by a 
few rare variants of high penetrance (mainly copy number variants and translocations) and many 
common variants of small penetrance (SNPs and variable number of tandem repeats) (68). As each 
SNP very minimally impacts schizophrenia risk and is compatible with modern models of natural 
selection (67), it is expected that other genetic factors are needed, in the same individual, to increase 
the liability to a point of schizophrenia onset. For example, the Ser704Cys site affects interaction with 
nuclear distribution element-like 1 (NDEL1) and its homolog Nuclear Distribution Element 1 (NDE1, 
also known as NudE) (69, 70), and there is evidence for an interaction between NDEL1 rs1391768 
and the Ser704 allele and the NDE1 rs3784859 and the Cys704 allele on the risk for schizophrenia in 
European participants (71). Ser704Cys is also the binding site for proteins such as kendrin (also 
known as pericentrin PCNT) and Pericentriolar material 1 (PCM1) (72), which have been both 
described as risk factor genes for schizophrenia (73). Furthermore, environmental factors such as 
exposure to psychosocial stress may also interact with the Ser704Cys polymorphism to affect 
dopamine function and mediate risk for schizophrenia (15). Interestingly, using a transgenic 
expression of truncated human Disc1 protein with dominant-negative effect, Niwa et al. have shown 
that an interaction between DISC1 and stress exposure, as a 3 week social isolation paradigm, 
increased dopamine release after amphetamine challenge (34) and induced alterations in DNA 
methylation of the tyrosine hydroxylase gene (74). 
 
Evidence also suggests that the Ser704Cys polymorphism is a risk factor for affective disorders. The 
cysteine allele has been associated with major depression in Japanese population (47), and shown to 
form a protective haplotype for bipolar spectrum disorder with two others DISC1 SNPs (rs1411771 
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and rs980989) in Finnish population (75), whereas a higher serine allele rate has been found in South 
Indian population with bipolar disorder (76). Interestingly, increased dopamine synthesis capacity is 
seen in both mania (77) and bipolar psychosis (78), whilst major depression with affective flattening is 
characterized by a decreased synthesis capacity (79, 80). 
 
The Ser704Cys SNP has also been shown to have a functional impact at the brain level (39). 
Compared to healthy cysteine homozygotes and heterozygotes, serine homozygotes display increased 
(for the same level of performance, thus putatively inefficient) prefrontal cortex activation in the left 
middle and left superior frontal gyri and in the homologous right superior frontal gyrus, the left 
inferior frontal and cingulate cortex, the thalamus and the caudate nucleus in a verbal fluency task 
(81), as well as an effect on thalamic-prefrontal connectivity (82). Ser704Cys SNP has also been 
shown to affect activation during declarative memory task with inconsistent findings. Callicott et al 
(48) found decreased activation bilaterally in the hippocampal formation during a declarative memory 
task and increased activation bilaterally in the hippocampal formation in an N-back task in Ser704 
homozygotes controls compared to cysteine homozygotes and heterozygotes, whereas Di Giorgio et al 
(83) found increased hippocampal formation/dorsolateral prefrontal cortex coupling during memory 
encoding in a declarative memory task in serine homozygotes compared to healthy cysteine 
homozygotes and heterozygotes. 
 
In summary, our results provide unprecedented preliminary evidence that DISC1 Ser704Cys has an 
impact on the dopamine synthesis capacity, in a large sample of 102 healthy volunteers. Further 
studies should aim at 1) replicating this result in different cohorts; 2) investigating potential epistatic 
interactions with DISC1 and other risk genes. Genetic studies based on molecular evidence could help 
identify the molecular mechanism that underlies the pathoaetiology of dopamine-related disorders 
such as psychotic disorders, and help identify novel potential treatment targets (15). 
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Conclusion 
We found that the serine allele of DISC1 Ser704Cys (rs821616) was associated with significantly 
higher striatal dopamine synthesis capacity, consistently with its previous association with heightened 
activation of ERK1/2 which stimulates tyrosine hydroxylase activity for dopamine synthesis. This 
implicates the DISC1 polymorphism in altering a psychosis relevant mechanism in the brain i.e. the 
facilitation of greater dopamine synthesis capacity. Although, this effect of rs821616 may be of too 
small effect to be identified in population-based studies of end state diagnoses at their current large 
size, it continues to implicate the functional role of DISC1. Firstly by highlighting the role of this 
polymorphism at this gene in creating variation within the normal functioning of the brain, but also by 
indicating this function as a potential mechanism through which other rare or familial mutations for 
major mental illnesses could disrupt functioning and increase risk to these devastating disorders. 
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Material and Methods 
Overview 
All participants gave informed written consent to take part after full description of the study. All 
studies were approved by the institutional review board and the local research ethics committee. 
Participants 
Participants were recruited via advertisement in local media based in London. One hundred and 
twenty-three participants underwent a [18F]-DOPA PET scan. For all participants the inclusion criteria 
were 1) age above 18 years; 2) capacity to give written informed consent. The exclusion criteria were 
1) any current medical conditions or history of medical condition (past minor self-limiting conditions 
were permitted); 2) history of a psychiatric disorder as determined by the Structured Clinical Interview 
for DSM-IV Axis 1 Disorders, Clinician Version (SCID-CV) (84); 3) history of substance 
abuse/dependence as determined by the Structured Clinical Interview for DSM-IV Axis 1 Disorders, 
Clinician Version (SCID-CV) (84); 4) history of head injury with a loss of consciousness; 5) a family 
history of any psychotic disorder in first- or second-degree relatives; 6) contraindications to positron 
emission tomography (PET) scanning (significant prior exposure to radiation, pregnancy or breast 
feeding). All participants provided urine samples prior to the scan to screen for drug use and 
pregnancy test in women. Six participants were excluded due to positive urine THC screening, 12 
participants were excluded to contamination of samples and 3 participants were excluded due to 
current psychotropic medication use. This resulted in the final inclusion of 102 participants (46 
females/56 males, age: 30.2±9.3 years (mean±Standard Deviation). Both scanning and imaging 
analysis were done blind to the genotype status. 
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[
18
F]-FDOPA PET 
PET data were acquired using three different PET scanners. PET scanner 1 was an ECAT HR+ 962 
PET scanner (CTI/Siemens, Knoxville, Tennessee). The dynamic images were acquired in 3D mode 
with an axial field of view of 15.5 cm and reconstructed using filterback projection. PET scanners 2 
and 3 were two Siemens Biograph HiRez XVI PET-CT scanner (Siemens Healthcare, Erlangen, 
Germany) at Imanova, Centre for Imaging Sciences. PET scanner 1 and PET scanner 2-3 were 
identical with the only exception of the axial field of view: 16.2 cm vs 21.6 cm respectively. The 
dynamic images were also reconstructed using a 3D filtered back-projection algorithm (discrete 
inverse Fourier transform, DIFT) with a 128 matrix, a zoom of 2.6 and a 5mm isotropic Gaussian 
smoothing. Participants were scanned at various times of the day. Some of the imaging data has been 
included in prior reports but not for genetic analysis (85-88). For attenuation and model-based scatter 
correction, a 10 min transmission scan was performed using a 150-MBq cesium-137 rotating point 
source for the ECAT HR+ 962 PET scanner and a computed tomography scan (effective 
dose=0.36 mSv) for the Siemens Biograph HiRez XVI PET-CT scanners were acquired prior to each 
PET scan. Experimental protocol was consistent for all the participants (85). Participants were asked 
to fast and abstain from smoking from midnight on the day of the scan as tobacco use has been 
associated with increased striatal dopamine synthesis capacity (89) although this has not been 
replicated (85). Oral doses of carbidopa (150mg) and entacapone (400mg) were administrated 1 hour 
before scanning. While the first reduces the peripheral metabolism of the tracer (90), the latter 
minimizes the formation of radiolabeled [18F]-FDOPA metabolites, which can cross the blood-brain 
barrier (91). Head movement was monitored and minimized with a light head strap. If participants 
moved extensively during the acquisition or got out of the scanner a second attenuation correction 
image was acquired at the end of the acquisition. PET data were acquired dynamically during 95 
minutes after bolus injection of the radioactive tracer [
18
F]-DOPA through a cannula inserted into a 
vein. Dynamic data were binned into 26 frames (PET scanner 1) and 32 frames (PET scanner 2 and 3). 
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Image Analysis 
Head movement was corrected using a frame-by-frame realignment and denoising algorithm (92) with 
a level 2 order 64 Battle-Lemarie wavelet filter applied on the non- attenuation-corrected dynamic 
images. These images were used because they include a significant scalp signal compared to 
attenuation-corrected images (93). Frames were realigned to a reference frame corresponding to the 
frame with the highest number of counts, i.e. obtained 7 minutes (for the ECAT HR+ 962 PET 
scanner-CTI/Siemens, Knoxville, Tennessee) and 17 minutes (for the Siemens Biograph HiRez XVI 
PET-CT scanners-Siemens Healthcare, Erlangen, Germany) after the radiotracer injection using a 
mutual information algorithm (94). The transformation parameters were then applied to the 
corresponding attenuation-corrected dynamic images. These realigned frames were summated, 
creating a movement-corrected dynamic image from which to extract the Time Activity Curves (TAC) 
for graphical analysis quantification. Standardized regions in Montreal Neurologic Institute (MNI) 
space were defined in the striatum delineated as previously described to create a Region of Interest 
(ROI) map (95) and in the cerebellum using the probabilistic Martinez atlas (95, 96). The cerebellum 
was used as a reference region as it is largely devoid of dopaminergic neurons or projections (45). A 
nonlinear transformation procedure on SPM8 (http://www.fil.ion.ucl.ac.uk/spm) was used to 
normalize the ROI map together with the [18F]-DOPA template to each individual PET summation 
image, in order to place the ROI automatically on individual [
18
F]-DOPA PET dynamic images. Influx 
constant Ki
cer
 value, (min
-1
) for the striatum was calculated relative to uptake in the reference region 
using a graphical approach (97), a method which has been shown to have good reliability (95). 
Genetic analysis 
DNA was extracted from blood or cheek swabs using standard methods (98). Genotyping of the 
rs821616 A>T SNP, was performed by KBioscience (Herts, UK, http://www.kbioscience.co.uk) using 
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a competitive allele specific Polymerase Chain Reaction system (CASP). Quality control procedures 
included negative control (water) wells and duplicate wells.  
Statistical analysis 
The normality of the distribution for all variables was examined using the Shapiro Wilk test, 
inspection of Q-Q plots and skewness and kurtosis values within range of ± 2. Homogeneity of 
variance was assessed with Levene’s Test for Equality of Variances. An alpha threshold was set at 
0.05 (two-tailed) for significance for all statistical comparisons. Statistical Package for the Social 
Sciences (SPSS) version 24 was used for all statistical analysis (IBM, Armonk, N.Y.). All data are 
shown as mean±SD. An univariate analysis of covariance (ANCOVA) was performed on 102 healthy 
controls, with the DISC1 SNP Ser704Cys variation (serine homozygotes versus cysteine homozygotes 
and heterozygotes) as the independent variable, Ki
cer in the striatum as the dependent variable and age, 
gender, ethnicity (table 1) and the three PET scanners separately as covariates as these variables have 
been previously found to influence dopamine synthesis capacity (99, 100). Effect sizes are reported as 
partial eta squared. Independent t test and Mann-Whitney test were used to compare age and injected 
dose. 
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Legend to Figure 
Figure 1: Mean (SEM) striatal dopamine synthesis capacity (Ki
cer value, min-1) in DISC1 rs821616 cysteine homozygotes and 
heterozygotes (TT and TA, N=56) and DISC1 rs821616 serine homozygotes (AA, N=46). Dopamine synthesis capacity was 
significantly increased in serine homozygotes compared with cysteine homozygotes and heterozygotes (F (1,96)=6.555, 
p=0.012). 
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Table 
Table 1   DISC1 SNP rs821616   
  Total cysteine homozygotes 
and heterozygotes 
serine 
homozygotes 
P value 
Total genotype counts 102 45 (AT) and 11 (TT) 46 (AA)  
Females 46 21 25 
PET scanner 1 35 19 16  
0.549 
iii
 PET scanner 2 33 16 17 
PET scanner 3 34 21 13 
     
Age 30.2 (9.3) 31.5 (9.9) 28.6 (8.4) 0.115
i
 
Tobacco smoking 
status (nonsmoker) 
75 43 32  
0.411
ii
 
Tobacco smoking 
status (smoker) 
27 13 14 
Radioactivity injected 
(MBq) 
157.7 (16.2) 156.6 (16.2) 159.2 (16.4) 0.529
ii
 
White European 70 35 35  
 
0.503
iii
 
Black British/other 22 15 7 
Asian British/other 5 3 2 
Mixed ethnicity 5 3 2 
All data ± SD. 
i 
Independent t test 
ii
 Mann-Whitney U test 
iii
 Pearson Chi-Square 
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Genome-wide association study (GWAS) 
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Nuclear distribution element-like 1 (NDEL1) 
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Statistical Package for the Social Sciences (SPSS) 
Structured Clinical Interview for DSM-IV Axis 1 Disorders, Clinician Version (SCID-CV) 
Time Activity Curves (TAC) 
[
18
F] fluoro-3,4-dihydroxyphenyl-L-alanine (F-DOPA) 
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